Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P. Moorman

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Journal of Virology|August 23, 2013
KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infectionJia M Wang, Yong Q Cheng, Lei Shi, et al.
Plos One|February 6, 2014
Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockadeCheng J Ma, Jun P Ren, Guang Y Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2011
Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infectionYing Zhang, Cheng J Ma, Lei Ni, et al.
Immunology|November 25, 2010
PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infectionCheng J Ma, Lei Ni, Ying Zhang, et al.
AIDS (London, England)|March 10, 2016
Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individualsLing Wang, Juan Zhao, Jun P Ren, et al.
Viral Immunology|October 2, 2010
Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infectionAshley D Frazier, Chun L Zhang, Lei Ni, et al.
Drugs in R&D|May 25, 2025
An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil FumarateDerek E Murrell, Benjamin C Kennard, Maria E Bertoni, et al.
Vaccine|March 8, 2011
Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responsesJonathan P Moorman, Chun L Zhang, Lei Ni, et al.
Frontiers in Genome Editing|October 24, 2024
The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruptionZhi Q Yao, Madison B Schank, Juan Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infectionJonathan P Moorman, Jia M Wang, Ying Zhang, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Journal of Virology|August 23, 2013
KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infectionJia M Wang, Yong Q Cheng, Lei Shi, et al.
Plos One|February 6, 2014
Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockadeCheng J Ma, Jun P Ren, Guang Y Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2011
Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infectionYing Zhang, Cheng J Ma, Lei Ni, et al.
Immunology|November 25, 2010
PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infectionCheng J Ma, Lei Ni, Ying Zhang, et al.
AIDS (London, England)|March 10, 2016
Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individualsLing Wang, Juan Zhao, Jun P Ren, et al.
Viral Immunology|October 2, 2010
Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infectionAshley D Frazier, Chun L Zhang, Lei Ni, et al.
Drugs in R&D|May 25, 2025
An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil FumarateDerek E Murrell, Benjamin C Kennard, Maria E Bertoni, et al.
Vaccine|March 8, 2011
Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responsesJonathan P Moorman, Chun L Zhang, Lei Ni, et al.
Frontiers in Genome Editing|October 24, 2024
The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruptionZhi Q Yao, Madison B Schank, Juan Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infectionJonathan P Moorman, Jia M Wang, Ying Zhang, et al.
Pageof 10